Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


07.05.2018

1 Ann Oncol
1 Cancer Chemother Pharmacol
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
2 J Natl Cancer Inst
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. DUSKA LR, Kohn EC
    The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.
    Ann Oncol. 2017;28.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  2. LEE J, Curtin JP, Muggia FM, Pothuri B, et al
    Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer.
    Cancer Chemother Pharmacol. 2018 Apr 27. pii: 10.1007/s00280-018-3591.
    PubMed     Text format     Abstract available


    Cancer Lett

  3. MENG Y, Chen CW, Yung MMH, Sun W, et al
    DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.
    Cancer Lett. 2018 Apr 25. pii: S0304-3835(18)30296.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. MATSUDA T, Leisegang M, Park JH, Ren L, et al
    Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer.
    Clin Cancer Res. 2018 May 2. pii: 1078-0432.CCR-18-0142.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  5. NTOUMANOGLOU-SCHUIKI A, Tomasch G, Laky R, Taumberger N, et al
    Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
    Eur J Obstet Gynecol Reprod Biol. 2018;225:110-112.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  6. CRAMER DW, Elias KM
    Perspectives on Ovarian Cancer From SEER: Today and Tomorrow.
    J Natl Cancer Inst. 2018 Apr 28. pii: 4990609. doi: 10.1093.
    PubMed     Text format    

  7. PERES LC, Cushing-Haugen KL, Kobel M, Harris HR, et al
    Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
    J Natl Cancer Inst. 2018 Apr 28. pii: 4990606. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  8. ZHANG T, Xu J, Deng S, Zhou F, et al
    Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.
    PLoS One. 2018;13:e0196351.
    PubMed     Text format     Abstract available

  9. AITHAL A, Junker WM, Kshirsagar P, Das S, et al
    Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
    PLoS One. 2018;13:e0193907.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: